Matsuzaki J - Search Results

1

A rare population of tumor antigen-specific CD4⁺CD8⁺ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.

Matsuzaki J, Tsuji T, Chodon T, Ryan C, Koya RC, Odunsi K. Matsuzaki J, et al. J Immunother Cancer. 2019 Jan 9;7(1):7. doi: 10.1186/s40425-018-0467-y. J Immunother Cancer. 2019. PMID: 30626427 Free PMC article.

2

An efficient method to prepare T cell receptor gene-transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell-therapy.

Tsuji T, Chamoto K, Funamoto H, Kosaka A, Matsuzaki J, Abe H, Fujio K, Yamamoto K, Kitamura T, Togashi Y, Koda T, Nishimura T. Tsuji T, et al. Among authors: matsuzaki j. Cancer Sci. 2003 Apr;94(4):389-93. doi: 10.1111/j.1349-7006.2003.tb01452.x. Cancer Sci. 2003. PMID: 12824910 Free PMC article.

3

Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.

Chamoto K, Kosaka A, Tsuji T, Matsuzaki J, Sato T, Takeshima T, Iwakabe K, Togashi Y, Koda T, Nishimura T. Chamoto K, et al. Among authors: matsuzaki j. Cancer Sci. 2003 Oct;94(10):924-8. doi: 10.1111/j.1349-7006.2003.tb01377.x. Cancer Sci. 2003. PMID: 14556668 Free PMC article.

4

Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo.

Matsuzaki J, Tsuji T, Chamoto K, Takeshima T, Sendo F, Nishimura T. Matsuzaki J, et al. Cell Immunol. 2003 Aug;224(2):98-105. doi: 10.1016/j.cellimm.2003.08.009. Cell Immunol. 2003. PMID: 14609575

5

Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells.

Chamoto K, Tsuji T, Funamoto H, Kosaka A, Matsuzaki J, Sato T, Abe H, Fujio K, Yamamoto K, Kitamura T, Takeshima T, Togashi Y, Nishimura T. Chamoto K, et al. Among authors: matsuzaki j. Cancer Res. 2004 Jan 1;64(1):386-90. doi: 10.1158/0008-5472.can-03-2596. Cancer Res. 2004. PMID: 14729649

6

NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.

Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T. Chamoto K, et al. Among authors: matsuzaki j. Immunol Lett. 2004 Aug 15;95(1):5-11. doi: 10.1016/j.imlet.2004.04.012. Immunol Lett. 2004. PMID: 15325792

7

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

Tsuji T, Yasukawa M, Matsuzaki J, Ohkuri T, Chamoto K, Wakita D, Azuma T, Niiya H, Miyoshi H, Kuzushima K, Oka Y, Sugiyama H, Ikeda H, Nishimura T. Tsuji T, et al. Among authors: matsuzaki j. Blood. 2005 Jul 15;106(2):470-6. doi: 10.1182/blood-2004-09-3663. Epub 2005 Mar 24. Blood. 2005. PMID: 15790789 Free article.

8

1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation.

Matsuzaki J, Tsuji T, Zhang Y, Wakita D, Imazeki I, Sakai T, Ikeda H, Nishimura T. Matsuzaki J, et al. Cancer Sci. 2006 Feb;97(2):139-47. doi: 10.1111/j.1349-7006.2006.00144.x. Cancer Sci. 2006. PMID: 16441425 Free PMC article.

9

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.

Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S, Shrikant P, Old LJ, Gnjatic S. Odunsi K, et al. Among authors: matsuzaki j. Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12837-42. doi: 10.1073/pnas.0703342104. Epub 2007 Jul 25. Proc Natl Acad Sci U S A. 2007. PMID: 17652518 Free PMC article. Clinical Trial.

10

Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.

Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Matsuzaki J, et al. Cancer Immunol Immunother. 2008 Aug;57(8):1185-95. doi: 10.1007/s00262-008-0450-4. Epub 2008 Feb 6. Cancer Immunol Immunother. 2008. PMID: 18253733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters